JP2015129189A5 - - Google Patents

Download PDF

Info

Publication number
JP2015129189A5
JP2015129189A5 JP2015077340A JP2015077340A JP2015129189A5 JP 2015129189 A5 JP2015129189 A5 JP 2015129189A5 JP 2015077340 A JP2015077340 A JP 2015077340A JP 2015077340 A JP2015077340 A JP 2015077340A JP 2015129189 A5 JP2015129189 A5 JP 2015129189A5
Authority
JP
Japan
Prior art keywords
composition
mucositis
ulcer
inflammation
substituent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015077340A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015129189A (ja
JP6000397B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015129189A publication Critical patent/JP2015129189A/ja
Publication of JP2015129189A5 publication Critical patent/JP2015129189A5/ja
Application granted granted Critical
Publication of JP6000397B2 publication Critical patent/JP6000397B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015077340A 2010-04-06 2015-04-06 キトサン化合物を用いて創傷を処置するための方法および組成物 Active JP6000397B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32143710P 2010-04-06 2010-04-06
US61/321,437 2010-04-06
US201161451430P 2011-03-10 2011-03-10
US61/451,430 2011-03-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013503881A Division JP2013523827A (ja) 2010-04-06 2011-04-06 キトサン化合物を用いて創傷を処置するための方法および組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015237188A Division JP2016033164A (ja) 2010-04-06 2015-12-04 キトサン化合物を用いて創傷を処置するための方法および組成物

Publications (3)

Publication Number Publication Date
JP2015129189A JP2015129189A (ja) 2015-07-16
JP2015129189A5 true JP2015129189A5 (https=) 2016-01-28
JP6000397B2 JP6000397B2 (ja) 2016-09-28

Family

ID=44763261

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2013503881A Pending JP2013523827A (ja) 2010-04-06 2011-04-06 キトサン化合物を用いて創傷を処置するための方法および組成物
JP2015077340A Active JP6000397B2 (ja) 2010-04-06 2015-04-06 キトサン化合物を用いて創傷を処置するための方法および組成物
JP2015237188A Withdrawn JP2016033164A (ja) 2010-04-06 2015-12-04 キトサン化合物を用いて創傷を処置するための方法および組成物
JP2017194973A Withdrawn JP2017226706A (ja) 2010-04-06 2017-10-05 キトサン化合物を用いて創傷を処置するための方法および組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013503881A Pending JP2013523827A (ja) 2010-04-06 2011-04-06 キトサン化合物を用いて創傷を処置するための方法および組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015237188A Withdrawn JP2016033164A (ja) 2010-04-06 2015-12-04 キトサン化合物を用いて創傷を処置するための方法および組成物
JP2017194973A Withdrawn JP2017226706A (ja) 2010-04-06 2017-10-05 キトサン化合物を用いて創傷を処置するための方法および組成物

Country Status (7)

Country Link
US (5) US9439925B2 (https=)
EP (1) EP2555760B1 (https=)
JP (4) JP2013523827A (https=)
AU (1) AU2011237682B2 (https=)
CA (1) CA2795520C (https=)
ES (1) ES2773017T3 (https=)
WO (1) WO2011127144A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3144324A1 (en) 2006-06-02 2017-03-22 Synedgen, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
CA3004707C (en) 2009-09-02 2022-05-31 Synedgen Inc. Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds
EP2555760B1 (en) 2010-04-06 2019-10-16 Synedgen, Inc. Chitosan derivatives for the treatment of mucositis or ulceration
WO2013134129A2 (en) * 2012-03-05 2013-09-12 Synedgen, Inc. Derivatized polyglucosamines for delivery of small molecules, peptides, and proteins
CN102755662B (zh) * 2012-07-25 2014-01-08 福州乾正药业有限公司 一种复合壳聚糖凝胶膜及其制备方法
WO2014047506A1 (en) 2012-09-20 2014-03-27 Synedgen, Inc. Methods for treatment or prevention of damage resulting from radiation, trauma or shock
TWI478943B (zh) * 2012-12-27 2015-04-01 Ind Tech Res Inst 高分子組成物用於製備具有抑制基質金屬蛋白酶之活性的功效的醫療器材或抑制劑的用途
CN103893813B (zh) * 2012-12-28 2018-04-17 财团法人工业技术研究院 高分子组合物与高分子材料
JP6842916B2 (ja) 2013-03-12 2021-03-17 シネジェン, インコーポレイテッド 非発酵性糖と組み合わせたポリグルコサミン誘導体の経口製剤
WO2014172040A1 (en) * 2013-03-15 2014-10-23 Synedgen Inc. Compositions and methods of use for wound healing
EP3034085B1 (en) * 2013-08-13 2019-10-23 Seikagaku Corporation Drug containing cationized chitosan
US9259357B2 (en) 2014-04-16 2016-02-16 Loma Linda University Composition, preparation, and use of chitosan shards for biomedical applications
CA2960998A1 (en) 2014-09-11 2016-03-17 Synedgen, Inc. Compositions and methods of use thereof
KR20180066240A (ko) * 2015-10-30 2018-06-18 크로마-파르마 게젤샤프트 엠.베.하. 무균 수성 안과용 액제의 치료적 용도
RU2741912C2 (ru) 2015-10-30 2021-01-29 Крома-Фарма Гезелльшафт М.Б.Х. Применение в терапии стерильного водного офтальмологического раствора
WO2017161113A1 (en) * 2016-03-16 2017-09-21 Synedgen, Inc. Compositions and methods of their use
CN108096182A (zh) * 2016-11-25 2018-06-01 哈尔滨盈聚生物科技有限公司 一种基于绿色抗菌材料的妇科抗菌凝胶及其制备方法
US10918699B2 (en) * 2017-03-22 2021-02-16 Michael C. Struck Therapeutic treatment for neurotrophic keratopathy
WO2018202783A1 (en) 2017-05-03 2018-11-08 Croma-Pharma Gmbh Sterile aqueous ophthalmic solution containing n-(n-acetylcysteinyl)-chitosan for treating non-infectious corneal disorders
TWI633888B (zh) * 2017-10-03 2018-09-01 黃琮瑋 醣類物質用於製備改善嗅覺功能的藥物之用途
CN107970269A (zh) * 2017-12-30 2018-05-01 广州润虹医药科技股份有限公司 一种含有壳聚糖的口腔溃疡膜及其制备方法
RU2697869C1 (ru) * 2018-04-28 2019-08-21 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) Фармацевтическая субстанция для лечения инфицированных ран различного генеза
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
WO2021221656A1 (en) 2020-04-30 2021-11-04 Synedgen, Inc. Compositions and methods of use thereof
EP4406542A1 (en) 2023-01-26 2024-07-31 BioKuris Treatment of gut inflammatory diseases

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4532134A (en) 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
JPH09510961A (ja) * 1994-01-14 1997-11-04 ジュニア シャヒニアン,リー 持続性および長期間の角膜鎮痛の方法
US7214202B1 (en) 1997-07-28 2007-05-08 Kci Licensing, Inc. Therapeutic apparatus for treating ulcers
EP1061937A1 (en) 1998-03-10 2000-12-27 University Of Southern California Improved radiation therapy methods
BR9912627A (pt) 1998-07-30 2002-02-13 Nutriceuticals Inc E Composição em suspensão lìquida estável, e, processos para preparação e uso da mesma e para tratamento de peso e de colesterol
US6114382A (en) 1998-11-11 2000-09-05 Moretti; Itagiba G. Methods for treating inflammatory bowel disease
DE69828451T2 (de) * 1998-11-20 2006-01-12 Laboratoire Medidom S.A. Wässrige ophthalmische formulierungen mit chitosan
US6962151B1 (en) 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
JP2003012702A (ja) * 2001-04-24 2003-01-15 Sankyo Co Ltd 低分子キトサンの製造方法
ATE481110T1 (de) 2002-07-16 2010-10-15 Biosyntech Canada Inc Zusammensetzung für die herstellung zellkompatibler, injizierbarer, selbstgelierender chitosan lösungen zum einkapseln und verabreichen von lebenden zellen oderbiologisch aktiven faktoren
GB2393120A (en) 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
GB0302741D0 (en) 2003-02-06 2003-03-12 Advanced Biopolymers As Use
GB0303085D0 (en) 2003-02-11 2003-03-19 Pfizer Ltd Model
MX2007001018A (es) 2004-07-26 2007-08-07 Kci Licensing Inc Metodo para recubrir un sustrato con un agente antimicrobiano y un producto formado por el mismo.
CN1965650A (zh) 2005-11-14 2007-05-23 陈祖辉 多元金属离子螯合的甲壳素绿色抗菌剂
EP3144324A1 (en) 2006-06-02 2017-03-22 Synedgen, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
KR20200075044A (ko) 2008-01-22 2020-06-25 아라임 파마슈티칼즈, 인크. 조직 손상 관련 질환 및 장애를 예방 및 치료하기 위한 조직 보호 펩티드 및 펩티드 유사체
CA2723848C (en) * 2008-05-09 2013-01-08 Regenics As Method of making salmon egg cytoplasmic extracts and use for increasing collagen production in skin
WO2010021930A1 (en) * 2008-08-16 2010-02-25 Synedgen, Inc. Prevention and treatment of mrsa infections with chitosan-derivatives
WO2010025267A2 (en) 2008-08-29 2010-03-04 The General Hospital Corporation Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase
EP2364153B1 (en) 2008-11-12 2015-05-06 Synedgen, Inc. Chitosan derivatives to optimize animal weight gain
US8916542B2 (en) 2008-11-12 2014-12-23 Synedgen, Inc. Chitosan derivatives, compositions and related methods of use
EP2391387A1 (en) 2009-01-29 2011-12-07 Synedgen, Inc. Nucleic acid delivery using modified chitosans
CN102458419A (zh) 2009-06-10 2012-05-16 埃克塞拉医学有限责任公司 组合物用于治疗粘膜炎的用途
CA3004707C (en) * 2009-09-02 2022-05-31 Synedgen Inc. Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds
JP2013503897A (ja) 2009-09-02 2013-02-04 シネジェン, インコーポレイテッド キトサン誘導体化合物を用いる口腔ケア方法および組成物
EP2555760B1 (en) 2010-04-06 2019-10-16 Synedgen, Inc. Chitosan derivatives for the treatment of mucositis or ulceration
AU2012279209A1 (en) 2011-07-01 2014-01-23 Synedgen, Inc. Methods and compositions of reducing and preventing bacterial growth and the formation of biofilm on a surface utilizing chitosan-derivative compounds
US8735571B2 (en) 2011-12-22 2014-05-27 Agenta Biotechnologies, Inc. Composition, preparation, and use of dense chitosan membrane materials
WO2013134129A2 (en) 2012-03-05 2013-09-12 Synedgen, Inc. Derivatized polyglucosamines for delivery of small molecules, peptides, and proteins
WO2014047506A1 (en) 2012-09-20 2014-03-27 Synedgen, Inc. Methods for treatment or prevention of damage resulting from radiation, trauma or shock
JP6842916B2 (ja) 2013-03-12 2021-03-17 シネジェン, インコーポレイテッド 非発酵性糖と組み合わせたポリグルコサミン誘導体の経口製剤
WO2014172040A1 (en) 2013-03-15 2014-10-23 Synedgen Inc. Compositions and methods of use for wound healing
CA2960998A1 (en) 2014-09-11 2016-03-17 Synedgen, Inc. Compositions and methods of use thereof
WO2018202783A1 (en) 2017-05-03 2018-11-08 Croma-Pharma Gmbh Sterile aqueous ophthalmic solution containing n-(n-acetylcysteinyl)-chitosan for treating non-infectious corneal disorders
US11390408B2 (en) 2020-11-24 2022-07-19 Axon Llc System and method for applying tubular bands to containers utilizing angled band ejection

Similar Documents

Publication Publication Date Title
JP2015129189A5 (https=)
JP2018530592A5 (https=)
WO2018152353A3 (en) Pentaaza macrocyclic ring complexes for local intestinal delivery
JP2013544244A5 (https=)
JP2017515888A5 (https=)
JP2007500176A5 (https=)
JP2014525749A5 (https=)
JP2015534956A5 (https=)
Clearfield et al. Emphysematous gastritis secondary to lye ingestion: Report of a case
JP4620169B1 (ja) 有機酸重合体を有効成分とするクローン病の予防又は治療剤
Lee et al. Various upper endoscopic findings of acute esophageal thermal injury induced by diverse food: a case series
Rodríguez et al. Upper gastrointestinal bleeding due to gastric and duodenal Kaposi's sarcoma
Rashid et al. Occult Gastrointestinal Bleeding Secondary to Gastric Amyloidosis in an HIV-Infected Patient: 103
Almashhrawi et al. Elmiron-induced Colitis: A Rare Complication: 344
Bolla et al. Gastrointestinal Profile and Efficacy in Rats of the Cyclooxygenase-Inhibiting Nitric Oxide Donator (CINOD) Compound NCX 429: 104
Kaplan et al. Acute Hemorrhagic Colitis in 25 Year Old Man Treated for Flu like Symptoms: 607
Tesfaye et al. Colonic Spirochetes in a Patient With HIV: 1353
Mendu et al. Isolated Gastric Malakoplakia Associated with Helicobacter Pylori Infection: A Case Report and Review of Literature: 608
McGowan et al. Oral Sulfate Solution Provides Superior Overall and Segmental Colon Cleansing to Split-dose Sodium Picosulfate and Magnesium Citrate: 1973
Tong et al. A Rare Cause of Mediastinitis From Colonic Interposition for Esophageal Atresia: 1728
Mukherjee et al. Recurrent Signet-Cell Type Gastric Cancer Simulating Ulcerative Colitis: 606
Chiplunker et al. Widely Metastatic Colon Cancer After Previous Prostate Irradiation: 1352
Piscaglia et al. Patchy left-sided colitis: primary eosinophilic colitis or paraneoplastic syndrome?
Siopi AB055. Long term NIV
Hamadah Colonic ischemia: case report